XTANDI is a prescription medicine used to treat men with prostate cancer that:
- no longer responds to a hormone therapy or surgical treatment to lower testosterone
- has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone
OR
It is not known if XTANDI is safe and effective in females or children.
Pay as little as
$0 per month.
It's all about
having a game
plan
XTANDI was proven to help men with advanced prostate cancer delay progression and live longer
Proven results in 3 types of advanced prostate cancer
In a study with 1,150 men, XTANDI lowered the chance of progression by 61%.
The median* length of time until the cancer got worse was not reached for XTANDI + ADT** vs. 19 months for ADT alone.
Progression was defined as the cancer getting worse, as measured by scans, or if the patient died for any reason.
In this same study, XTANDI helped men live longer.
XTANDI significantly improved overall survival by 34% vs ADT alone.
The median length of time patients lived after starting treatment was not reached.
In a study with 1,717 men, XTANDI lowered the chance of progression by 83%.
The median length of time until the cancer got worse was not reached for XTANDI + ADT vs. 4 months for ADT alone.
Progression was defined as the cancer getting worse, as measured by scans, or if the patient died for any reason.
In this same study, XTANDI helped men live longer. The median overall survival was 35 months for men taking XTANDI + ADT vs. 31 months for ADT alone.
In a study with 1,401 men, XTANDI lowered the chance of progression by 71%.
The median length of time until the cancer spread was 37 months for XTANDI + ADT vs. 15 months for ADT alone.
Progression was defined as the cancer spreading, as measured by scans, or if the patient died for any reason.
In this same study, XTANDI helped men live longer. The median overall survival was 67 months for men taking XTANDI + ADT vs. 56 months for ADT alone.
Results may vary. Talk with your doctor about what this may mean for you.
*The median is not the average but the middle of a set of numbers.
**ADT= Androgen Deprivation Therapy.
Select Safety Information
XTANDI may cause serious side effects, including seizure. If you take XTANDI, you may be at risk of having a seizure. Avoid activities where a sudden loss of consciousness could seriously harm you or someone else. Tell your doctor right away if you lose consciousness or have a seizure.
#1 prescribed branded novel hormone therapy
for advanced prostate cancer by oncologists and urologists.
Based on IQVIA NBRx rolling 4-week data, February 2021-January 2022.
THIS INFORMATION DOES NOT IMPLY SAFETY OR EFFICACY OF ANY PRODUCT. NO COMPARISONS SHOULD BE MADE.
Since FDA approval in 2012, 209,000 patients have been prescribed XTANDI †
Create a Game Plan with Your Doctor
Use this Doctor Discussion Guide for help with questions you may want to ask your doctor at your next visit.
Create a Game Plan with Your Doctor
Sign Up for More Information
Whether you’re a patient or caregiver, you’re not fighting alone. We’re here for you with tools, tips, information, and support.
Copay Assistance for Commercially Insured Patients
The XTANDI Patient Savings Program* is for eligible patients who have commercial prescription insurance.
Copay Assistance for Commercially Insured Patients
The XTANDI Patient Savings Program* is for eligible patients who have commercial prescription insurance.
